Turnstone Biologics Analyst Ratings
Turnstone Biologics Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/15/2023 | 70.5% | Piper Sandler | → $20 | Initiates Coverage On | → Overweight |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 08/15/2023 | 70.5% | 派珀·桑德勒 | → 20 美元 | 启动覆盖开启 | → 超重 |
What is the target price for Turnstone Biologics (TSBX)?
Turnstone Biologics（TSBX）的目标价格是多少？
The latest price target for Turnstone Biologics (NASDAQ: TSBX) was reported by Piper Sandler on August 15, 2023. The analyst firm set a price target for $20.00 expecting TSBX to rise to within 12 months (a possible 70.50% upside). 1 analyst firms have reported ratings in the last year.
派珀·桑德勒于2023年8月15日公布了Turnstone Biologics（纳斯达克股票代码：TSBX）的最新目标股价。这家分析公司将目标股价定为20.00美元，预计TSBX将在12个月内升至20.00美元（可能上涨70.50％）。去年有1家分析公司公布了评级。
What is the most recent analyst rating for Turnstone Biologics (TSBX)?
分析师对Turnstone Biologics（TSBX）的最新评级是多少？
The latest analyst rating for Turnstone Biologics (NASDAQ: TSBX) was provided by Piper Sandler, and Turnstone Biologics initiated their overweight rating.
Turnstone Biologics（纳斯达克股票代码：TSBX）的最新分析师评级由派珀·桑德勒提供，Turnstone Biologics启动了增持评级。
When is the next analyst rating going to be posted or updated for Turnstone Biologics (TSBX)?
Turnstone Biologics（TSBX）的下一个分析师评级何时公布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Turnstone Biologics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Turnstone Biologics was filed on August 15, 2023 so you should expect the next rating to be made available sometime around August 15, 2024.
分析师在进行了广泛的研究，包括浏览公开财务报表、与Turnstone Biologics的高管和客户交谈以及听取财报电话会议后得出股票评级。大多数分析师每三个月进行一次评级，因此每家公司每年应该获得4个评级。Turnstone Biologics的最后一次评级是在2023年8月15日提交的，因此你应该预计下一个评级将在2024年8月15日左右公布。
Is the Analyst Rating Turnstone Biologics (TSBX) correct?
分析师对Turnstone Biologics（TSBX）的评级正确吗？
While ratings are subjective and will change, the latest Turnstone Biologics (TSBX) rating was a initiated with a price target of $0.00 to $20.00. The current price Turnstone Biologics (TSBX) is trading at is $11.73, which is within the analyst's predicted range.
尽管评级是主观的，会发生变化，但最新的Turnstone Biologics（TSBX）评级是最初的，目标股价为0.00美元至20.00美元。Turnstone Biologics（TSBX）目前的交易价格为11.73美元，在分析师的预测区间内。